Real-world outcomes in elderly ALL patients with and without allogeneic hematopoietic stem cell transplantation: a single-center evaluation over 10 years

Elderly patients (EP) of 60 years and above with acute lymphoblastic leukemia (ALL) have a dismal prognosis, but pediatric-inspired chemotherapy and allogeneic stem cell transplantation (allo HCT) are used reluctantly due to limited data and historical reports of high treatment-related mortality in...

Descripción completa

Detalles Bibliográficos
Autores principales: Hofer, Kevin D., Schanz, Urs, Schwotzer, Rahel, Nair, Gayathri, Manz, Markus G., Widmer, Corinne C.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2022
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8993731/
https://www.ncbi.nlm.nih.gov/pubmed/35182191
http://dx.doi.org/10.1007/s00277-022-04793-z

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8993731/
https://www.ncbi.nlm.nih.gov/pubmed/35182191
http://dx.doi.org/10.1007/s00277-022-04793-z

Ejemplares similares